In this issue of Neuron, Tang et al. (2014) explore the relationship between developmental dendritic pruning, elevated mTORC1 signaling, macroautophagy, and autism spectrum disorder. The study provides valuable new insight into mTORC1-dependent cellular dysfunction and neurodevelopmental disorders.
Autism spectrum disorder (ASD) currently affects up to 1 in 68 children worldwide (http://www.cdc.gov/mmwr/preview/mm wrhtml/ss6302a1.htm?s_cid=ss6302a1_ w). Although monogenic disorders with a high incidence of ASD and mutations in genes that increase the risk for ASD have been identified, the genetic causes of ASD are largely unknown, highlighting the crucial need to determine whether there is convergence of molecular signaling among ASD patients to provide for novel therapeutic targets. Dysregulated protein synthesis has been implicated as a potential common converging mechanism in ASD (Santini et al., 2013) , but the involvement of other mechanisms for proteostatic regulation such as degradation and autophagy has not been well characterized. Macroautophagy is the process of breaking down of unused proteins and damaged cellular organelles, and although implicated in multiple neurodegenerative disorders (Fecto et al., 2014) , it has not been studied widely in either neurodevelopment or in ASD. Tang and colleagues (2014) , uncover a novel mechanistic contribution of macroautophagy (autophagy) to ASD, unveiling a new potential avenue for investigation, and potentially therapeutic targets. Tang et al. (2014) found that dendritic spine density in human ASD and control brains was similar earlier in life (ages 2-9), which then declined in control brains (ages 13-20) but not in ASD brains, suggesting that there may be disruption in synaptic pruning in individuals with ASD. The increase in spine density in the ASD brains was correlated with elevated phosphorylation of mammalian target of rapamycin (mTOR) and one of its downstream effectors, ribosomal protein S6, which has been observed previously in mouse models and humans with monogenic syndromes with high incidence of ASD (Hoeffer and Klann, 2010; Bhattacharya et al., 2012) . It is well known that activation of mTOR, when in a complex with Raptor (mTORC1), stimulates capdependent translation initiation and elongation, thereby increasing protein synthesis. Although excessive activation of mTORC1 has been linked to increased dendritic spine density and aberrant behavior in mouse models of ASD (Santini et al., 2013; Bhattacharya et al., 2012; Tsai et al., 2012) , the demonstration that elevated mTORC1 signaling is correlated with increased spine density late in brain development in human ASD patients by Tang et al. (2014) is novel. To further dissect the precise mTORC1 effectors that are responsible for the lack of developmental spine pruning in ASD, Tang and colleagues focused on LC3-ii, a marker of autophagosomes, and p62, an autophagy protein substrate. LC3-ii was decreased both in early and late development in ASD patient brains, and p62 levels were increased, suggesting that autophagy is decreased in ASD both early and late in development. Considering that mTORC1 signaling negatively regulates autophagy, Tang and colleagues sought to further explore the mechanistic relationship between elevated mTORC1 signaling, decreased autophagy, and increased spine density in mouse models of ASD. Toward this end, they utilized tuberous sclerosis complex 1 and 2 (Tsc1 and Tsc2) mutant mice, which are upstream negative regulators of mTORC1. In humans, mutations that result in either haploinsufficiency or reduced activity of TSC1 and TSC2 lead to tuberous sclerosis complex (TSC), which has a high incidence of ASD. In addition, mouse models of TSC display ASD-like behaviors (Ché vere-Torres et al., 2012; Tsai et al., 2012) . Tang et al. (2014) found that Tsc1 and Tsc2 mutant mice (Tsc1
CKO
and Tsc2 +/À ) had increased spine density later in development. Moreover, Tsc2 +/À mice exhibited increased mTORC1 signaling and reduced LC3-ii levels, suggesting decreased autophagy, which was correlated with impairments in novel object recognition and social novelty behavior. In addition, the dendritic spine phenotypes in the TSC-deficient mice were corrected with the mTORC1 inhibitor rapamycin. These findings are consistent with earlier reports that Tsc1 mutant mice exhibit behavioral abnormalities that can be rescued by rapamycin (Tsai et al., 2012) .
The role of autophagy in dendritic pruning and ASD-like behaviors was further examined by the authors in mice lacking Atg7, which is essential for autophagosome formation. Neuronal Atg7 conditional knockout mice (Atg7 CKO ) displayed deficits in pruning and behavioral aberrations similar to the Tsc2 +/À mice, but these phenotypes were not fully rescued by rapamycin. Moreover, when mouse neurons in culture were treated with Atg7siRNA at a ''mature'' developmental stage, there was decreased synaptic elimination, but not synapse formation, further suggesting that autophagy is required specifically for synapse elimination. These data are consistent with previous studies showing that stimulating mTORC1 signaling increases spine formation and density, which is sensitive to disruption of mTORC1 and its effectors involved in translation control (Bowling et al., 2014; Lee et al., 2011; Bhattacharya et al., 2012; Kumar et al., 2005) . Although elevated mTORC1 signaling may correspond with increased spine turnover, the majority of the data indicate that a long-term reduction in mTORC1 signaling is correlated with reduced spine density (Jiang et al., 2013; Kumar et al., 2005) . Thus, activation of mTORC1 signaling likely regulates dendritic spine formation and/or maintenance, and autophagy likely regulates spine elimination.
To further distinguish the contribution of the mTORC1 pathway to autophagy from other cellular processes in this context, the authors generated Tsc2 +/À Atg7 CKO double mutant mice.
The double mutant mice had reduced dendritic pruning that was not completely reversed by rapamycin, in contrast to Tsc2 +/À mice, which showed improvement with rapamycin. Similarly, Tsc2
mutant mice also exhibited impairments in novel object recognition and social behavior, which did not fully respond to rapamycin treatment. These results suggest that the rescue of the improper dendritic pruning by rapamycin is in part due to effects on autophagy and that other downstream effectors of mTORC1 contribute. In addition, these data further support the hypothesis that it is not solely dysregulated protein synthesis that is responsible for mTORC1-dependent increased spine density and aberrant social behavior in ASD patients and ASD model mice. In addition, previous reports suggest TSC mutant model mice exhibit decreased protein synthesis (Auerbach et al., 2011) , which differs from other ASD models where downstream mTORC1 signaling is increased (Santini et al., 2013; Bhattacharya et al., 2012) . This key divergence suggests that in TSC, mTORC1-mediated regulation of signaling pathways other than translational control are involved, as well as a role for TSC1/2 in balancing mTORC1-dependent autophagy. Thus, disruptions in the TSC1/2-mTORC1 autophagy pathway may be a point of convergence in the heterogeneous ASD patient population.
Based on their findings, Tang and colleagues put forward two novel and very important ideas. First, autophagy is critical to developmental dendritic spine pruning, and second, both mTORC1 signaling and autophagy are disrupted and do not undergo normal developmental shifts in ASD brains (Figure 1 ). These exciting findings raise additional intriguing questions. Previous studies have demonstrated that ASD model mice with genetic mutations associated with mTORC1 signaling and protein synthesis have disrupted synaptic plasticity, particularly metabotropic glutamate receptor-dependent long-term depression (mGluR-LTD) in the hippocampus (Ché vere-Torres et al., 2012; Bhattacharya et al., 2012; Santini et al., 2013; Bateup et al., 2011; Auerbach et al., 2011) . However, in contrast to translation, the role of autophagy in altered mGluR-LTD has not been addressed. In dopaminergic neurons, the deletion of Atg7 results in decreased neurotransmission (Hernandez et al., 2012) , consistent with the notion that disruption of the mTORC1 and Atg7 pathways could impact synaptic function. In contrast to the studies of Tang et al., the bulk of the previous studies were not performed in the temporal cortex, which raises questions of how increased spine number, reduced pruning, and decreased autophagy alter the electrical signature of synapses and whether these phenomena have regional specificity. This is especially important given that, in the hippocampus, Tsc1 +/À mice had alterations in membrane capacitance and increased glutamatergic-related synaptic currents, despite having no overall changes in spine density (Bateup et al., 2011) , suggesting that there may be regional specificity in neuronal abnormalities in TSC model mice. Another question is the potential accumulation of proteins and their identity, as other ASD model mice have been shown to have excessive protein synthesis (Santini et al., 2013; Bhattacharya et al., 2012) . Finally, does reducing autophagy, which is normally associated with the breakdown of proteins and organelles, result in oversized lysosomes, increased accumulation of proteins, and/or other cellular abnormalities in ASD?
In summary, Tang et al. have reshaped the landscape of ASD research focus by introducing an mTORC1-dependent, but potentially translation-independent, signaling cascade that could underlie the synaptic pruning deficits associated with ASD. In addition, they demonstrated a In control brains, there is a developmental decrease in mTORC1 signaling that corresponds to balanced autophagy (LC3-ii) and a decrease in spine number. In ASD brains, there is no developmental decrease in mTORC1 signaling, and thus, there is a reduction in autophagyrelated markers. The disruption in mTORC1 signaling is correlated with increased spine density at later developmental stages, whereas control brains have undergone synaptic pruning. This disruption of both mTORC1 signaling and autophagy in TSC model mice leads to similar spine abnormalities and autistic-like behaviors. Together, this model proposes a role for mTORC1 and autophagy in the developmental pruning of dendritic spines and that the disruption of this balance of may contribute to the pathology of ASD.
novel role for autophagy in developmental dendritic spine pruning that provides further insight into this carefully regulated shaping of synaptic connections that when dysregulated could contribute to the behavioral deficits observed in ASD.
Critical unmet clinical needs are the treatment of epilepsy without side effects and prevention of sudden unexpected death in epilepsy, or SUDEP. In this issue of Neuron, Qi et al. (2014) , define how hyper-SUMOylation impacts K + channel activity in vivo and could serve as a potential pathway for development of novel epilepsy therapeutics.
The rate of sudden death in patients with epilepsy is over 20 times higher than in the general population (Shorvon and Tomson, 2011) . Sudden unexpected death in epilepsy, or SUDEP, is the primary cause of mortality in patients with epileptic disorders. Although SUDEP is clearly linked to mutations in ion channels (Auerbach et al., 2013; Glasscock et al., 2010; Goldman et al., 2009; Kalume et al., 2013; Massey et al., 2014; Surges and Sander, 2012) , the specific underlying pathophysiological mechanism(s) remains elusive, and biomarkers are not currently available. Thus, SUDEP represents a major unmet clinical need and a current focus of intense investigation. Animal model and clinical studies show that, in addition to neuronal synchrony and hyperexcitability, respiratory and cardiovascular abnormalities during and after seizures contribute to SUDEP, suggesting important interactions between brain and heart. In this issue of Neuron, Qi et al. (2014) give new perspective to the growing list of potential SUDEP mechanisms, proposing that genes within the ion channel protein interactome may be pathogenic candidates.
Looking beyond mutations in ion channels themselves, Qi and colleagues (Qi et al., 2014) examine the in vivo role of the dynamic processes of SUMOylation on neuronal excitability and its relationship to SUDEP and seizures. SUMOylation, the addition of ubiquitin-like SUMO-modifying groups to lysine residues, and subsequent de-SUMOylation by Sentrin/SUMO-specific protease (SENPs), is known to alter protein function and localization in multiple tissues, including brain and heart (Droescher et al., 2013; Wang, 2011) . To explore the role of SENP2 in SUMOylation in vivo, Qi et al. generated a floxed SENP2 allele. Unexpectedly, the authors found that SENP fxN/fxN mice, in which the neomycin cassette was retained within the floxed SENP2 allele, developed spontaneous convulsive seizures and died at 6-8 weeks with 100% penetrance.
